ÂÜÀòÂÒÂ×

Joanne Gibbons serves as Morphic’s Senior Vice President of Regulatory Affairs. In this role, Ms Gibbons leads all regulatory functions and is responsible for overseeing the development and execution of regulatory strategies for Morphic’s development pipeline.

Ms. Gibbons has over 20 years of experience in Regulatory Affairs and Clinical Development, both in the development of novel drugs and the expansion of marketed products. Before joining Morphic in 2022, she served as Vice President and Head of Regulatory Affairs at Codiak Biosciences where she oversaw the regulatory function that led to clinical trials of the first candidates to emerge from Codiak’s engEX™ platform.

Prior to Codiak, Ms. Gibbons was Senior Director, Regulatory Affairs at Wave Life Sciences, and prior to that, she held positions of increasing responsibility in Clinical Development and Regulatory Affairs at Biogen for nearly two decades, culminating as Interim Head of Global Regulatory Strategy. Ms. Gibbons holds a BA from Tufts University.